Whitney P Kirschbrown

4PUBLICATIONS
13CO-AUTHORS
Counselling, wellbeing and community servicesCancer therapy (excl. chemotherapy and radiation therapy)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 12, 2021
Reply to J. Wei et al.

Nancy U Lin, Mark Pegram, Solmaz Sahebjam

|Sep 24, 2021
Correction to: Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Bei Wang, Rong Deng, Stefanie Hennig

|Jun 09, 2021
Population pharmacokinetic and exploratory exposure-response analysis of the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer in the FeDeriCa study.

Bei Wang, Rong Deng, Stefanie Hennig

|May 04, 2021
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study.

Nancy U Lin, Mark Pegram, Solmaz Sahebjam

Pageof 1

Frequent Collaborators

2 joint publications

Nancy U Lin

2 joint publications

Mark Pegram

2 joint publications

Nuhad Ibrahim

2 joint publications

Chunze Li